Meeting Notice - North Dakota Medicaid Drug Use Review Board (Sept. 4, 2024)

North Dakota Medicaid Drug Use Review Board 
Wednesday, Sept. 4, 2024
1:00 - 4:00 p.m. CT

In-Person Information
Conference Room 210/212, 2nd Floor, Judicial Wing, State Capitol
600 E. Boulevard Ave., Bismarck, ND 58505

Virtual Information
Join by computer: Click here to join the meeting
Join by phone: 701-328-0950, conference ID # 506 213 519

Agenda

• Call to Order
• Roll Call
• Review and Approval of Minutes
• Reports from Department
  • Administrative Report
  • Financial Report: Top Drugs
  • Retrospective DUR Report
  • Clinical Report:
    • Prior Authorization Update
    • Criteria updates: asthma/COPD, chronic kidney disease, Duchenne muscular dystrophy, growth hormone, heart failure, hereditary angioedema, hypertrophic cardiomyopathy, lipid-lowering treatment, plaque psoriasis, medications over $3000, dry eye disease
• Unfinished Business
• New Business
  • Second Review of Molluscum Contagiosum (Ycanth and Zelsuvmi)
  • Second Review of Epidermolysis Bullosa (Filsuvez)
  • Second Review of Metabolic Dysfunction–Associated Steatohepatitis (Rezdiffra)
  • First Review of Attention-Deficit Hyperactivity Disorder Stimulants
  • Review of retrospective DUR criteria recommendations
• Announcements: Next Meeting (December 4, 2024)
• Adjourn

Individuals who need accommodations in order to participate or who would like information about joining the meeting can contact Ashley Gerving at 701-328-2354, 711 (TTY) or gervingashley@nd.gov.

Date Posted: January 18, 2024 
Date Revised: August 22, 2024 (agenda/meeting details added)